Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. - Wikidata - awgldk - TriplyDB

Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group.

Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group.

http://www.wikidata.org/entity/Q50664942

about

The role of cryptococcal antigen assay in diagnosis and monitoring of cryptococcal meningitis A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada)Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA Fungal colonization of the brain: anatomopathological aspects of neurological cryptococcosis Cryptococcus gattii infections The Cryptococcus neoformans capsule: lessons from the use of optical tweezers and other biophysical tools Species in the Cryptococcus gattii Complex Differ in Capsule and Cell Size following Growth under Capsule-Inducing Conditions Spread ofCryptococcus gattiiinto Pacific Northwest Region of the United States Treatment of cryptococcosis in the setting of HIV coinfection.Regulation of hypoxia adaptation: an overlooked virulence attribute of pathogenic fungi?Cryptococcus gattii: an emerging fungal pathogen infecting humans and animals.A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease.Management of Cryptococcus gattii meningoencephalitis.Cryptococcosis mimicking cutaneous cellulitis in a patient suffering from rheumatoid arthritis: a case report.Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART era.Genetic diversity of the Cryptococcus species complex suggests that Cryptococcus gattii deserves to have varieties.Cryptococcal meningitis: epidemiology and therapeutic options.Puerperal brain cryptococcoma in an HIV-negative woman successfully treated with fluconazole: a case report.Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis.Clonality and α-a recombination in the Australian Cryptococcus gattii VGII population--an emerging outbreak in Australia.Heteroresistance of Cryptococcus gattii to fluconazole.Cyclic AMP-dependent protein kinase controls virulence of the fungal pathogen Cryptococcus neoformans Molecular typing of IberoAmerican Cryptococcus neoformans isolates Cryptococcus neoformans hyperfilamentous strain is hypervirulent in a murine model of cryptococcal meningoencephalitis.Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.Comparative gene genealogies indicate that two clonal lineages of Cryptococcus gattii in British Columbia resemble strains from other geographical areas.Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999-2007.MALDI-TOF MS enables the rapid identification of the major molecular types within the Cryptococcus neoformans/C. gattii species complex.Cryptococcus gattii infection dampens Th1 and Th17 responses by attenuating dendritic cell function and pulmonary chemokine expression in the immunocompetent hosts.Phenotypic switching in a Cryptococcus neoformans variety gattii strain is associated with changes in virulence and promotes dissemination to the central nervous system Unisexual reproduction of Cryptococcus gattii.Central nervous system cryptococcoma in a Ugandan patient with Human Immunodeficiency Virus Clinical utility of the cryptococcal antigen lateral flow assay in a diagnostic mycology laboratory.A case-control study of risk factors for HIV-negative children with cryptococcal meningitis in Shi Jiazhuang, China.Retrospective study of the epidemiology and clinical manifestations of Cryptococcus gattii infections in Colombia from 1997-2011.Most cases of cryptococcal meningitis in HIV-uninfected patients in Vietnam are due to a distinct amplified fragment length polymorphism-defined cluster of Cryptococcus neoformans var. grubii VN1.Epidemiology of cryptococcal meningitis in the US: 1997-2009.Carbon dioxide is a powerful inducer of monokaryotic hyphae and spore development in Cryptococcus gattii and carbonic anhydrase activity is dispensable in this dimorphic transition.Microbiological, epidemiological, and clinical characteristics and outcomes of patients with cryptococcosis in Taiwan, 1997-2010

P2860

Q24538877-CDD70698-AC50-4A1B-A3CE-EA64B4CE8830 Q24558831-309E02C1-804C-43DD-A9B3-D4B3B3BFFD71 Q24652835-3A409DE2-AB3D-4B46-B823-A2ECE0212ED2 Q26801588-ABA6CD17-3FD0-44E6-B918-762DE335F307 Q27002687-EF5F55F3-449F-4900-9AF8-8127B2168EF2 Q28087622-9717A98D-C9B8-435E-BC64-65ECD917C1F6 Q28818460-1B20933C-AD71-468F-9FE7-5463C1B57E89 Q30048584-5497BDBB-B9B3-4C2C-8956-C2040571476D Q30366117-B767C00C-1E38-46A8-8651-86C61BD24AE4 Q30377415-AC00E638-4195-42A5-AA8F-C91E0B73EF75 Q30403990-128D9AB8-3F4C-46B4-B2CB-9CB750ED3C21 Q30495712-54BDE7B3-4AF7-448D-897A-6F69E656FC6F Q30873978-24037ED3-A68C-47E9-8EEF-0D26E6C88EF8 Q30987023-A3060EBD-147B-4F65-A4FD-655450FE523D Q33272469-7E76C608-C489-445F-B4AC-83C5D92AE4ED Q33328474-33216062-CF53-447C-929D-DC5F3DC97ED7 Q33466055-FF6B9FAF-5AB0-4BBD-BA0C-2833F2C32271 Q33633343-7FE5660D-BFA2-4562-B151-7B034C794524 Q33707104-FAC10FC8-B8B1-4350-897C-F44B3B081FA3 Q33790656-BEE3BF0B-C6B5-42A5-A602-87D92277BB6B Q33839536-49AA79D6-6179-4D33-8CD2-147FAB8B5823 Q33876577-09DDFC1E-2B06-4D2B-97AE-323F68C4F27C Q33968048-A4C72FCC-66A6-4A53-8B24-D7AFEF62B6E6 Q33984407-D2D64F21-C246-4988-A766-8FB9B10CBF51 Q34005219-8F981F9B-5720-4BE0-BFD0-01DD0B752152 Q34020746-2452E96C-BA84-4CE1-8094-B9285653EA9F Q34097624-D0586BF4-E8A8-4DC4-A9CA-21524C9289CA Q34216198-2CDC1F7B-5A0E-4BA4-B374-2C6FB3054E5F Q34292528-A9592D8F-E532-433E-8A6E-94E1304CEE51 Q34298459-DF32D577-71D6-4F5B-B407-CEA4B68311B4 Q34334384-64763836-BE6C-4A79-A0FB-9EF324533C32 Q34388703-773ABF6D-1A86-48DC-8907-BCB40C82F67C Q34436150-CBC637B6-6662-40DD-8B61-91184E56C6A7 Q34482498-13388A2D-8B2A-4231-9287-2AA027FCF0DB Q34522791-A96ACBFD-F8ED-48B9-8124-3717DD16EFA9 Q34549620-22C143C5-03F7-473B-93F3-ACF93996FEBB Q34596637-DCEF05D1-EA8A-4616-A0C9-3F836E078CBC Q34606681-3352E710-7A40-4462-AA1B-0F36C76B3B4B Q34639505-A698A85B-E63B-4099-996E-AB325345BB7F Q34685419-E6376986-541A-46D0-980A-66A19538FAE5

P2860

Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group.

http://www.wikidata.org/entity/Q50664942

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年学术文章

@wuu

2000年学术文章

@zh

2000年学术文章

@zh-cn

2000年学术文章

@zh-hans

2000年学术文章

@zh-my

2000年学术文章

@zh-sg

2000年學術文章

@yue

2000年學術文章

@zh-hant

name

Epidemiology and host- and var ...... sian Cryptococcal Study Group.

@en

Epidemiology and host- and var ...... sian Cryptococcal Study Group.

@nl

type

label

Epidemiology and host- and var ...... sian Cryptococcal Study Group.

@en

Epidemiology and host- and var ...... sian Cryptococcal Study Group.

@nl

prefLabel

Epidemiology and host- and var ...... sian Cryptococcal Study Group.

@en

Epidemiology and host- and var ...... sian Cryptococcal Study Group.

@nl

P1433

Q50664942-B701D7F1-5F3D-43E0-A63C-B183FCD9D5C1

P1476

Q50664942-46E842A7-AB6E-45B1-B671-B70CE29D270D

P2093

Q50664942-28EEFE0D-1BB1-47BF-931C-8FF09895EC83

Q50664942-2F12172D-6B6A-4D95-8CEF-ECF6178D9097

Q50664942-57599C43-0795-48FE-9981-7F5B6DD57486

Q50664942-692C4191-9EBA-43EF-9E2E-607343363FF5

Q50664942-6E8311D3-976F-401D-8092-BAD335889A5C

Q50664942-84D1AD0C-223A-4BE4-98B2-E78AC7559B31

Q50664942-8743516C-04D8-4EE9-9C01-F1AD87211332

Q50664942-BCC50101-A72D-472B-A85F-EC1D93032FDA

Q50664942-E03A1A70-C6FB-4B3D-8BF6-BC8BEC0344E6

P2860

Q50664942-0861C6FC-F9BD-42F3-95BF-3E5CD6DD7F77

Q50664942-1CEEEE9E-94BF-4E9E-A9D3-63CDED62F769

Q50664942-3627F344-EE57-40C5-BB06-CC68F06E0EA8

Q50664942-72342C41-F5F6-4C48-98CA-01C905956014

Q50664942-7BF675FB-ABB5-43D0-97D4-4B15D0C22EB6

Q50664942-8F594205-729F-4C26-A03B-515A73A8D815

Q50664942-B9AA4949-DA63-4A1C-9BD9-26F03B5397E8

Q50664942-C1C325CB-7420-49E4-98E4-987620CBEE91

Q50664942-DBF62096-8F5D-40D5-A48C-49C775D94E9A

Q50664942-ED2E6039-E8C2-4928-8B43-C9EA01E21676

P304

Q50664942-FEAE4918-BF72-42CD-9D20-1D0687C7EFC8

P31

Q50664942-820D5850-D5C7-46BD-A240-28669F2D45F8

P356

Q50664942-3E57B8AA-29E7-434E-81E0-181A26BAE5C0

P407

Q50664942-34AB5B48-B37A-43BD-8F74-94DB8C400F68

P433

Q50664942-8BD5C3B7-8470-4587-B3CD-AEE96D3BCCCC

P478

Q50664942-CB0B92F1-34E3-4D31-A9B3-4A11C329CE41

P50

Q50664942-ECD4E548-2700-492C-BD87-8482B40B55AA

P577

Q50664942-36D4A070-E75B-46C8-A0C8-10D4EF7F6F55

P698

Q50664942-B716AAB0-F517-45F3-AA73-72D800C50A0D

P921

Q50664942-2695053F-A4CD-422C-AB27-F02F2136FDA9

Q50664942-2A553958-C0CC-4CA0-A1B3-252AF9D4F676

P356

P1433

Clinical Infectious Diseases

P1476

Epidemiology and host- and var ...... sian Cryptococcal Study Group.

@en

P2093

Byth K

http://www.w3.org/2001/XMLSchema#string

Chen S

http://www.w3.org/2001/XMLSchema#string

Currie B

http://www.w3.org/2001/XMLSchema#string

Ellis D

http://www.w3.org/2001/XMLSchema#string

Marriott D

http://www.w3.org/2001/XMLSchema#string

Nimmo G

http://www.w3.org/2001/XMLSchema#string

Parr D

http://www.w3.org/2001/XMLSchema#string

Pfeiffer T

http://www.w3.org/2001/XMLSchema#string

Speed B

http://www.w3.org/2001/XMLSchema#string

P2860

The ecology of Cryptococcus neoformans.

Cryptococcus neoformans in tropical northern Australia: predominantly variant gattii with good outcomes.

Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome.

Cryptococcal meningitis in Durban, South Africa: a comparison of clinical features, laboratory findings, and outcome for human immunodeficiency virus (HIV)-positive and HIV-negative patients.

The incidence and spectrum of AIDS-defining illnesses in persons treated with antiretroviral drugs.

Pathology of cryptococcal meningoencephalitis: analysis of 27 patients with pathogenetic implications.

Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group.

Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City.

Glossary of terms for thoracic radiology: recommendations of the Nomenclature Committee of the Fleischner Society.

Exposure to Cryptococcus neoformans var. gattii--a seroepidemiological study.

P304

499-508

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/313992

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

P577

2000-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10987712

http://www.w3.org/2001/XMLSchema#string

P921